DR. SMET MARLEEN
0808.735.619 · rovalta.com · 25/09/2026
DR. SMET MARLEEN
Financial year 2025 · Closed on 30/06/2025
Overview
Identity
Source · BCE/KBODR. SMET MARLEEN is a Private company with limited liability incorporated in 2008. Its main activity is: General medical practice activities. Its registered office is in Mortsel.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0808.735.619
- Incorporation
- 29/12/2008
- Legal form
- Private company with limited liability
- Registered office
- Dieseghemlei 49
2640 Mortsel · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 30/06/2025
Financials
Source · NBB, 17 filingsTrend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 227,3 k € | -5.0% | 239,2 k € | +9.7% | 217,9 k € | -8.0% | 236,8 k € | -3.2% | 244,5 k € |
| EBITDA | 225,2 k € | -4.9% | 236,7 k € | +9.6% | 216 k € | -8.2% | 235,2 k € | -3.3% | 243,2 k € |
| Operating result | 224,2 k € | -4.8% | 235,6 k € | +15.8% | 203,4 k € | -8.5% | 222,4 k € | -3.7% | 230,9 k € |
| Net result | 154,9 k € | -3.4% | 160,4 k € | +16.6% | 137,6 k € | -10.6% | 153,8 k € | -1.9% | 156,8 k € |
| Balance sheet | |||||||||
| Equity | 1,2 M € | +14.3% | 1,1 M € | +17.3% | 921,2 k € | +17.4% | 784,4 k € | +24.2% | 631,4 k € |
| Total assets | 1,3 M € | +8.9% | 1,2 M € | +16.7% | 1 M € | +16.8% | 860,8 k € | +19.4% | 720,8 k € |
| Cash | 228,8 k € | +5.2% | 217,6 k € | +26.2% | 172,5 k € | -35.2% | 266,1 k € | +109% | 127,1 k € |
| Debts | 42,1 k € | -52.1% | 88 k € | +8.1% | 81,5 k € | +10.0% | 74 k € | -14.6% | 86,6 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/06/20241 active · 4 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 21/01/2026 | 05/02/2025 | 31/01/2024 | 30/01/2023 | 16/02/2022 | 26/01/2021 |
| General meeting | 20/12/2025 | 21/12/2024 | 16/12/2023 | 31/12/2022 | 31/12/2021 | 19/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 17 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2025 | 20/12/2025 | 21/01/2026 | Dutch | |
| Micro model | 30/06/2024 | 21/12/2024 | 05/02/2025 | Dutch | |
| Micro model | 30/06/2023 | 16/12/2023 | 31/01/2024 | Dutch | |
| Micro model | 30/06/2022 | 31/12/2022 | 30/01/2023 | Dutch | |
| Micro model | 30/06/2021 | 31/12/2021 | 16/02/2022 | Dutch | |
| Micro model | 30/06/2020 | 19/12/2020 | 26/01/2021 | Dutch | |
| Micro model | 30/06/2019 | 21/12/2019 | 15/01/2020 | Dutch | |
| Micro model | 30/06/2018 | 15/12/2018 | 30/01/2019 | Dutch | |
| Micro model | 30/06/2017 | 16/12/2017 | 29/01/2018 | Dutch | |
| Abridged model | 30/06/2016 | 17/12/2016 | 25/01/2017 | Dutch | |
| Abridged model | 30/06/2015 | 19/12/2015 | 13/01/2016 | Dutch | |
| Abridged model | 30/06/2014 | 20/12/2014 | 15/01/2015 | Dutch | |
| Abridged model | 30/06/2013 | 21/12/2013 | 12/02/2014 | Dutch | |
| Abridged model | 30/06/2012 | 15/12/2012 | 27/02/2013 | Dutch | |
| Abridged model | 30/06/2011 | 17/12/2011 | 28/12/2011 | Dutch | |
| Abridged model | 30/06/2010 | 18/12/2010 | 31/01/2011 | Dutch | |
| Abridged model | 30/06/2009 | 19/12/2009 | 20/01/2010 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20241 active · 4 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025154,9 k €↓
- 2024Annual accounts 2024160,4 k €↑
- 2023Annual accounts 2023137,6 k €↓
- 2022Annual accounts 2022153,8 k €↓
- 2021Annual accounts 2021156,8 k €↑
- 2020Annual accounts 2020104,5 k €↑
- 2019Annual accounts 201990,7 k €↑
- 2018Annual accounts 201884,6 k €↑
- 2017Annual accounts 201725,3 k €↓
- 2016Annual accounts 201635,5 k €↓
- 2015Annual accounts 201547,2 k €↓
- 2014Annual accounts 201451,3 k €↓
- 2013Annual accounts 201353,7 k €↑
- 2012Annual accounts 201249,5 k €↑
- 2011Annual accounts 201147 k €↓
- 2010Annual accounts 201049,5 k €↓
- 2009Annual accounts 200984,5 k €
- 29/12/2008IncorporationPrivate company with limited liability